• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


27.5900 USD 0.3800 1.40%

As of 10:17:32 ET on 09/19/2014.

Snapshot for Chimerix Inc (CMRX)

Open: 27.3100 Day's Range: 26.6000 - 27.7300 Volume: 48,829
Previous Close: 27.2100 52wk Range: 12.9600 - 30.9900 1-Yr Rtn: +39.05%

Stock Chart for CMRX

No chart data available.
  • CMRX:US 27.5900
  • 1D
  • 1M
  • 1Y
Interactive CMRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CMRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.3500
Est. EPS (USD) (12/2014) -1.6810
Est. PEG Ratio -
Market Cap (M USD) 970.57
Shares Outstanding (M) 35.67
30 Day Average Volume 365,473
Price/Book (mrq) 5.1173
Price/Sale (ttm) 214.9794
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CMRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CMRX

Chimerix, Inc. is a biopharmaceutical discoverers and commercializes oral antiviral therapeutics. The Company develops novel antiviral therapeutics with the potential to transform patient care in multiple settings including transplant, oncology, acute care, and global health. Chimerix operates in the United States.

M Michelle BerreyPres/CEO/Chief Medical OfficerWilliam Garrett NicholsChief Medical Officer
Linda M RichardsonChief Commercial OfficerMichael D RogersChief Development Officer
More Company Profile & Key Executives for CMRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil